Increasing Prevalence of Oral Diseases Worldwide to Augment the Benzocaine Market Growth

Benzocaine (also known as anaesthesin or americaine) is an active pharmaceutical ingredient that belongs to the class of organic compounds known as benzoic acid esters. It has various medicinal properties. Benzocaine is used as a pain relief drug in dental diseases such as dental caries and tooth decay, topical anesthetic in various diseases such as esophageal and mouth ulcers, for sexual disorders such as premature ejaculation, and to get rid of skin irritation such as vaginal irritation. Benzocaine is slightly soluble in water, manufactured in solid physical form, and its chemical name is Ethyl 4-aminobenzoate.

Worldwide, the increasing prevalence of oral/dental diseases (such as dental trauma, dental caries, and periodontitis) is driving the growth of the market. Oral diseases pose a major health burden for many countries and affect people throughout their lives, which may lead to heartburn, discomfort, pain, and even death. According to the World Health Organization (WHO), in 2017, oral diseases affect around 3.5 billion people and around 530 million children suffer from dental caries worldwide. Moreover, the increase in the prevalence of oral ulcers worldwide is also expected to propel the benzocaine market growth. In the U.K., 20% of the population are believed to be affected by recurrent aphthous ulceration.

The outbreak of COVID-19 (coronavirus) has affected almost every market and has also impacted the benzocaine market. The outbreak has affected the production and demand, as well as created disruptions in distribution channels. Manufacturing and supply chain activities in the U.S., China, and India have been disrupted due to nationwide lockdowns. However, in terms of geography, the benzocaine market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa.

North America is expected to witness substantial growth in the market due to the increasing product approvals and the presence of major key players in the region. Moreover, Key players active in the market are adopting various growth strategies (such as product launches, mergers and acquisitions, collaboration, etc.) to strengthen their market presence or to strengthen their product portfolio. For instance, in March 2019, Church and Dwight launched a new RepHresh Cooling Relief Vaginal Anti-Itch Spray to expand its product offerings. The new spray is meant to relieve feminine itch and neutralize odor, providing relief on contact, the company said.

Comments

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market